Cooling Eyedrops for Dry Eye Syndrome

This trial tests eyedrops called acoltremon (TRYPTYR) to determine if they can help people with evaporative dry eye by increasing the tear film's lipid layer and slowing tear evaporation. The goal is to improve dry eye symptoms by stimulating a cooling sensation on the eye surface, potentially boosting natural tear and oil production. Participants will receive either the treatment eyedrops or a placebo to compare results. The trial seeks individuals diagnosed with evaporative dry eye in the last 6 months who have not recently used certain eye medications or contact lenses. As a Phase 4 trial, this research involves an FDA-approved treatment and aims to understand its benefits for more patients.

Research has shown that acoltremon (TRYPTYR) 0.003% eye drops are generally safe for treating dry eye syndrome. In earlier studies involving individuals with dry eye disease, these eye drops increased tear production, and few participants discontinued use due to side effects. This suggests that most people can use the drops without issues.

Unlike standard treatments for dry eye syndrome, which typically focus on artificial tears or anti-inflammatory medications, Acoltremon (TRYPTYR) eye drops are unique because they incorporate a cooling effect. This innovative approach not only provides immediate soothing relief but also helps to reduce inflammation by lowering the temperature of the ocular surface. Researchers are excited about Acoltremon because its dual-action mechanism could offer faster and more effective relief for those suffering from dry eye symptoms.

Research has shown that acoltremon (TRYPTYR) 0.003% eye drops effectively treat dry eye syndrome. One study reported that 42.6% of patients experienced a significant increase in tear production, with at least a 10-mm increase in natural tears. Another study found even better results, with 53.2% of patients experiencing the same improvement. These findings suggest that the eye drops can help many people with dry eye by increasing tear production and improving symptoms. The eye drops activate TRPM8 receptors, creating a cooling sensation that may boost tear and oil production, helping to keep the eyes moist for longer. Participants in this trial will receive either the acoltremon eye drops or a placebo control to further evaluate their effectiveness.⁶⁷⁸⁹¹⁰